Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Drug Monitoring of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (DOSE-HEP)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2010 by South West Sydney Local Health District.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
South West Sydney Local Health District
ClinicalTrials.gov Identifier:
NCT01078311
First received: March 1, 2010
Last updated: NA
Last verified: February 2010
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2014
  Estimated Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)